JP2022513562A5 - - Google Patents
Info
- Publication number
- JP2022513562A5 JP2022513562A5 JP2021516582A JP2021516582A JP2022513562A5 JP 2022513562 A5 JP2022513562 A5 JP 2022513562A5 JP 2021516582 A JP2021516582 A JP 2021516582A JP 2021516582 A JP2021516582 A JP 2021516582A JP 2022513562 A5 JP2022513562 A5 JP 2022513562A5
- Authority
- JP
- Japan
- Prior art keywords
- kda
- protein
- serotypes
- polysaccharide
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024130732A JP2024160305A (ja) | 2018-09-23 | 2024-08-07 | 肺炎連鎖球菌の精製された莢膜多糖 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201841031653 | 2018-09-23 | ||
| IN201841031654 | 2018-09-23 | ||
| IN201841031654 | 2018-09-23 | ||
| IN201841031653 | 2018-09-23 | ||
| PCT/IB2019/058036 WO2020058963A1 (en) | 2018-09-23 | 2019-09-23 | Purified capsular polysaccharides of streptococcus pneumoniae |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024130732A Division JP2024160305A (ja) | 2018-09-23 | 2024-08-07 | 肺炎連鎖球菌の精製された莢膜多糖 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022513562A JP2022513562A (ja) | 2022-02-09 |
| JP2022513562A5 true JP2022513562A5 (cg-RX-API-DMAC7.html) | 2022-10-03 |
Family
ID=69886702
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021516582A Withdrawn JP2022513562A (ja) | 2018-09-23 | 2019-09-23 | 肺炎連鎖球菌の精製された莢膜多糖 |
| JP2024130732A Pending JP2024160305A (ja) | 2018-09-23 | 2024-08-07 | 肺炎連鎖球菌の精製された莢膜多糖 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024130732A Pending JP2024160305A (ja) | 2018-09-23 | 2024-08-07 | 肺炎連鎖球菌の精製された莢膜多糖 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12048739B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3852795A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2022513562A (cg-RX-API-DMAC7.html) |
| KR (1) | KR102879391B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN113164581A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019341723C1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021005425A2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021003358A (cg-RX-API-DMAC7.html) |
| MY (1) | MY206212A (cg-RX-API-DMAC7.html) |
| PH (1) | PH12021550539A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020058963A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202101663B (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10729763B2 (en) | 2017-06-10 | 2020-08-04 | Inventprise, Llc | Mixtures of polysaccharide-protein pegylated compounds |
| EP3720483B1 (en) | 2017-12-06 | 2025-11-19 | Merck Sharp & Dohme LLC | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| EP3897705A2 (en) | 2018-12-19 | 2021-10-27 | Merck Sharp & Dohme Corp. | Compositions comprising streptococcus pneumoniae polysaccharide-protein conjugates and methods of use thereof |
| CA3142692A1 (en) * | 2019-06-05 | 2020-12-10 | Merck Sharp & Dohme Corp. | An immunogenic serotype 35b pneumococcal polysaccharide-protein conjugate and conjugation process for making the same |
| AU2021262999A1 (en) | 2020-05-01 | 2023-01-19 | Sinocelltech Ltd. | Method for improving immunogenicity of protein/peptide antigen |
| US20230383324A1 (en) * | 2020-10-22 | 2023-11-30 | Pfizer Inc. | Methods for purifying bacterial polysaccharides |
| CA3200602A1 (en) * | 2020-11-04 | 2022-05-12 | Pfizer Inc. | Immunogenic compositions for use in pneumococcal vaccines |
| US20240123047A1 (en) * | 2021-02-04 | 2024-04-18 | Merck Sharp & Dohme Llc | Lipid nanoparticle adjuvant composition for pneumococcal conjugate vaccines |
| JP2025531339A (ja) * | 2022-09-19 | 2025-09-19 | バイオロジカル イー リミテッド | 莢膜ポリサッカライドの精製法 |
| CN117512031B (zh) * | 2023-10-16 | 2024-06-25 | 江苏金迪克生物技术股份有限公司 | 一种肺炎球菌荚膜多糖的纯化方法 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0027888B1 (en) | 1979-09-21 | 1986-04-16 | Hitachi, Ltd. | Semiconductor switch |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| EP0625910B1 (en) | 1992-02-11 | 2003-07-23 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Dual carrier immunogenic construct |
| DK0616034T3 (da) | 1993-03-05 | 2005-02-21 | Wyeth Corp | Plasmid til fremstilling af CRM-protein og diphtheria toxin |
| EP0720485B1 (en) | 1993-09-22 | 2003-11-19 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs |
| DE69628418T2 (de) | 1995-03-22 | 2004-04-01 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Herstellung von immunogenen konstrukten unter verwendung von löslichen kohlehydraten, die durch organische cyanylierungs-reagenzien aktiviert wurden |
| US6299881B1 (en) | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
| RU2672053C2 (ru) * | 2012-12-20 | 2018-11-09 | Пфайзер Инк. | Способ гликоконъюгации |
| FI3583947T3 (fi) * | 2014-01-21 | 2023-10-12 | Pfizer | Streptococcus pneumoniaen kapselipolysakkaridit ja niiden konjugaatit |
| IL312327B2 (en) | 2014-01-21 | 2026-02-01 | Pfizer | Immunogenic preparations comprising conjugated capsular saccharide antigens and their uses |
| MX388191B (es) | 2014-11-20 | 2025-03-19 | Biological E Ltd | Polinucleótido optimizado por codones para la expresión de alto nivel de crm197. |
| GB201518684D0 (en) * | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
| HUE049756T2 (hu) | 2015-11-09 | 2020-10-28 | Biological E Ltd | Ipari méretekben is alkalmazható eljárás biológiailag aktív, rekombináns hordozófehérjék kinyerésére |
| US11058757B2 (en) * | 2016-03-31 | 2021-07-13 | Pogona, LLC | Saccharide-polypeptide conjugate compositions and methods of use thereof |
| CN109789198B (zh) * | 2016-09-30 | 2024-08-16 | 生物E有限公司 | 包含多糖-蛋白缀合物的多价肺炎球菌疫苗组合物 |
| IL267709B2 (en) * | 2016-12-30 | 2025-04-01 | Vaxcyte Inc | Polypeptide-antigen conjugates with unnatural amino acids |
| JP7680185B2 (ja) * | 2017-02-24 | 2025-05-20 | メルク・シャープ・アンド・ドーム・エルエルシー | 肺炎連鎖球菌多糖-タンパク質コンジュゲートの免疫原性の増強 |
| BR112019022093A2 (pt) | 2017-04-22 | 2020-05-05 | Biological E Limited | método aprimorado para a produção em alto nível de crm |
| CN111065387B (zh) | 2017-09-07 | 2023-08-25 | 默沙东有限责任公司 | 肺炎球菌多糖及其在免疫原性多糖-载体蛋白缀合物中的用途 |
| HUE068482T2 (hu) | 2017-09-07 | 2025-01-28 | Merck Sharp & Dohme Llc | Pneumococcus-poliszacharidok és azok felhasználása immunogén poliszacharid-hordozóprotein konjugátumokban |
| CA3074706A1 (en) | 2017-09-07 | 2019-03-14 | Merck Sharp & Dohme Corp. | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
-
2019
- 2019-09-23 MX MX2021003358A patent/MX2021003358A/es unknown
- 2019-09-23 BR BR112021005425-1A patent/BR112021005425A2/pt not_active Application Discontinuation
- 2019-09-23 KR KR1020217011738A patent/KR102879391B1/ko active Active
- 2019-09-23 AU AU2019341723A patent/AU2019341723C1/en active Active
- 2019-09-23 JP JP2021516582A patent/JP2022513562A/ja not_active Withdrawn
- 2019-09-23 US US17/278,181 patent/US12048739B2/en active Active
- 2019-09-23 WO PCT/IB2019/058036 patent/WO2020058963A1/en not_active Ceased
- 2019-09-23 MY MYPI2021001583A patent/MY206212A/en unknown
- 2019-09-23 CN CN201980076246.8A patent/CN113164581A/zh active Pending
- 2019-09-23 EP EP19861817.5A patent/EP3852795A4/en not_active Withdrawn
-
2021
- 2021-03-11 PH PH12021550539A patent/PH12021550539A1/en unknown
- 2021-03-11 ZA ZA2021/01663A patent/ZA202101663B/en unknown
-
2024
- 2024-06-12 US US18/741,232 patent/US12465632B2/en active Active
- 2024-08-07 JP JP2024130732A patent/JP2024160305A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021512870A5 (cg-RX-API-DMAC7.html) | ||
| IL276229B2 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| TW202617178A (zh) | 多價肺炎球菌多醣-蛋白質共軛物組成物及使用其之方法 | |
| JP2021505589A5 (cg-RX-API-DMAC7.html) | ||
| JP2019526621A5 (cg-RX-API-DMAC7.html) | ||
| IL276230B2 (en) | Multivalent pneumococcal polysaccharide-protein conjugate composition | |
| JP2022542316A5 (cg-RX-API-DMAC7.html) | ||
| SA519401027B1 (ar) | تركيب متقارن من عديد السكاريد للمكورة الرئوية متعددة التكافؤ - وبروتين | |
| FI3720483T3 (fi) | Streptococcus pneumoniaen polysakkaridi-proteiinikonjugaatteja käsittäviä koostumuksia ja niiden käyttömenetelmiä | |
| JP2020533438A5 (cg-RX-API-DMAC7.html) | ||
| JP2020533437A5 (cg-RX-API-DMAC7.html) | ||
| HRP20110685T1 (hr) | Cjepivo od konjugata pneumokoknog polisaharida | |
| JP2019526620A5 (cg-RX-API-DMAC7.html) | ||
| PE20161095A1 (es) | Composiciones inmunogenicas que comprenden antigenos de sacaridos capsulares conjugados y uso de los mismos | |
| HRP20221438T1 (hr) | Postupak glikokonjugiranja | |
| PE20211888A1 (es) | Composiciones que comprenden conjugados de polisacarido de streptococcus pneumoniae con proteina y sus metodos de uso | |
| JP2020533442A5 (cg-RX-API-DMAC7.html) | ||
| RU2016136630A (ru) | Способы гликоконъюгирования и композиции | |
| EA200901578A1 (ru) | Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae | |
| JP2018516962A5 (cg-RX-API-DMAC7.html) | ||
| SA519401028B1 (ar) | تركيب متقارن من عديد السكاريد للمكورة الرئوية متعددة التكافؤ - وبروتين | |
| BR112015016817B1 (pt) | métodos para derivar um sacarídeo, para conjugar um derivado de sacarídeo e para incitar uma resposta imune em um mamífero, derivado de sacarídeo, conjugado de um derivado de sacarídeo, composição farmacêutica, e, uso de um conjugado ou composição farmacêutica | |
| CN108524926B (zh) | 一种多价肺炎球菌结合疫苗的制剂组合及其应用 | |
| WO2024241172A3 (en) | Methods for eliciting an immune response to respiratory syncycial virus and streptococcus pneumoniae infection | |
| NZ775208A (en) | Purified capsular polysaccharides of streptococcus pneumoniae |